Cilengitide, an integrin antagonist, has shown potential in the treatment of malignant glioma

By  

Inpharma, Vol. 1, Iss. 1589, 2007-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Sorafenib + dacarbazine shows advantages over dacarbazine monotherapy in the treatment of advanced melanoma

By  

Inpharma, Vol. 1, Iss. 1639, 2008-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma

By Hersh Evan   O’Day Steven   Powderly John   Khan Khuda   Pavlick Anna   Cranmer Lee   Samlowski Wolfram   Nichol Geoffrey   Yellin Michael   Weber Jeffrey  

Investigational New Drugs, Vol. 29, Iss. 3, 2011-06 ,pp. : 489-498

Springer Publishing Company

Access to resources Recommend Favorite

Agatolimod [PF-3512676] has potential as an adjuvant therapy in malignant melanoma

By  

Inpharma, Vol. 1, Iss. 1653, 2008-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

A phase I trial of imexon, a pro-oxidant, in combination with docetaxel for the treatment of patients with advanced breast, non-small cell lung and prostate cancer

By Moulder Stacy   Dhillon Navneet   Ng Chaan   Hong David   Wheler Jennifer   Naing Aung   Tse Susan   La Paglia Amy   Dorr Robert   Hersh Evan   Boytim Michelle   Kurzrock Razelle  

Investigational New Drugs, Vol. 28, Iss. 5, 2010-10 ,pp. : 634-640

Springer Publishing Company

Access to resources Recommend Favorite